Experimental arterial thrombosis regulated by androgen and its receptor via modulation of platelet activation.
OBJECTIVE
The aim of our study is to elucidate whether experimental arterial thrombosis is regulated by physiological doses of androgen and its receptor via modulation of platelet activation.


METHODS
Surgical castration was performed in male rats and ferric chloride (FeCl(3)), as a stimulator, induced the experimental arterial thrombosis. Testosterone was measured directly by chemiluminescent immunoassay on the Bayer ADVIA Centaur analyzer. Dihydrotestosterone (DHT) was determined by ELISA using a commercially available kit. A platelet aggregometer was used to assess aggregation, and a platelet adherometer was used to measure adhesion. The contents of TXB(2) and 6-Keto-PGF(1alpha) were assayed by radio-immunoassay using commercially available kits.


RESULTS
Our data showed that DHT replaced restored circulating DHT of castrated rats to physiological levels, without being altered by treatment with flutamide. Castration caused significant increases in the thrombus area and weight in castrated rats as compared with control group. In PRP diluted with autologous PPP, ADP-induced platelet aggregation rate was only 9.10%. However, in PRP diluted with Tyrode's buffer, 1 microM ADP-induced platelet aggregation rate rose to 63.65%. In PRP diluted with Tyrode's buffer, and pretreated with DHT (1 nM, 2 nM), ADP-induced platelet aggregation was significantly lowered again. Platelet aggregation in PRP diluted with autologous PPP was enhanced in castrated rats as compared with sham-operated rats, and DHT (2 nM) replacement suppressed platelet aggregation in castrated PRP to the level similar to that of sham-operated rats. However, presence of flutamide (3 microM) significantly increased platelet aggregation in PRP diluted with autologous PPP or Tyrode's buffer. DHT (2 nM) replacement significantly inhibited the ADP-induced platelet adhesion. However, presence of flutamide (3 microM) increased ADP-induced platelet adhesion again. DHT replacement obviously reduced the ratio of TXB(2) to 6-keto-PGF(1alpha) in castrated rats. However, administration of flutamide and DHT to castrated rats caused an increase in the ratio of TxB(2) to 6-keto-PGF1alpha.


CONCLUSIONS
Inhibition of experimental arterial thrombosis by androgen at physiological doses and its receptor is mediated via modulation of platelet activation.
Li
ShiJun
S
Division of Geriatric Cardiology, Chinese PLA General Hospital, Beijing, People's Republic of China. lishijun817@126.com
Li
XiaoYing
X
Li
Jian
J
Deng
XinLi
X
Li
Yan
Y
Cong
Yulong
Y
D015121:6-Ketoprostaglandin F1 alpha / Q000032:analysis; D000728:Androgens / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001158:Arteries; D002369:Castration; D002712:Chlorides; D013196:Dihydrotestosterone / Q000032:analysis; D005290:Ferric Compounds; D008297:Male; D015539:Platelet Activation / Q000187:drug effects* / Q000502:physiology*; D010973:Platelet Adhesiveness; D010974:Platelet Aggregation; D051381:Rats; D011944:Receptors, Androgen / Q000502:physiology*; D013739:Testosterone / Q000032:analysis; D013927:Thrombosis / Q000139:chemically induced / Q000188:drug therapy*; D013928:Thromboxane A2 / Q000032:analysis
D000728:Androgens; D002712:Chlorides; D005290:Ferric Compounds; D011944:Receptors, Androgen; D013196:Dihydrotestosterone; D013739:Testosterone; D013928:Thromboxane A2; D015121:6-Ketoprostaglandin F1 alpha; C024555:ferric chloride